Coronary artery bypass graft surgery. Mechanical complication of coronary artery bypass graft and biological heart valve graft
Conditions
Interventions
Intervention 1: Intervention group 1: In dexamethasone group, 8 mg dexamethasone (Iran Hormone Company) is used in the prime solution. In the first 24 hours after surgery, the patient receives 8 mg de
Sponsors
Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: All patients undergoing coronary artery bypass grafting surgery Consent to participate in the study
Exclusion criteria
Exclusion criteria: History of valve surgery Less than 40 years old and over than 60 years old Ejection fraction less than 40%
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding. Timepoint: After surgery. Method of measurement: Observation.;Hospitalization days. Timepoint: At the time of discharge. Method of measurement: Based on the day.;Inotrope intake. Timepoint: After the surgery. Method of measurement: Based on the recorded checklist.;Duration of mechanical ventialtion. Timepoint: At the time of discharge. Method of measurement: Based on the hour.;Arrhythmia. Timepoint: Continuously until discharge from cardiac intensive care unit. Method of measurement: Electrocardiogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehran Shahzamani
Esfahan University of Medical Sciences
Outcome results
None listed